Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16536638rdf:typepubmed:Citationlld:pubmed
pubmed-article:16536638lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0717758lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0231448lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0681906lld:lifeskim
pubmed-article:16536638lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:16536638pubmed:issue2lld:pubmed
pubmed-article:16536638pubmed:dateCreated2006-3-15lld:pubmed
pubmed-article:16536638pubmed:abstractTextThe impact of long-term therapy for rheumatoid arthritis (RA) in elderly (> or = 65 years of age) and younger (< 65 years of age) patients, especially on patient-reported outcomes, has not been well studied. We evaluated patient-reported outcomes in elderly patients treated with etanercept, in contrast to outcomes in younger patients, using data from multiple controlled and open-label extension studies of patients with early RA (ERA; < or = 3 years) and late RA (LRA; disease-modifying antirheumatic drug [DMARD]-refractory RA).lld:pubmed
pubmed-article:16536638pubmed:languageenglld:pubmed
pubmed-article:16536638pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:citationSubsetIMlld:pubmed
pubmed-article:16536638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16536638pubmed:statusMEDLINElld:pubmed
pubmed-article:16536638pubmed:issn1170-229Xlld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:DahlR ERElld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:GenoveseMark...lld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:WhiteBarbaraBlld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:WeinblattMich...lld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:MorelandLarry...lld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:SinghAmitabhAlld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:SchiffMichael...lld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:WoolleyJ...lld:pubmed
pubmed-article:16536638pubmed:authorpubmed-author:YuElaine BEBlld:pubmed
pubmed-article:16536638pubmed:issnTypePrintlld:pubmed
pubmed-article:16536638pubmed:volume23lld:pubmed
pubmed-article:16536638pubmed:ownerNLMlld:pubmed
pubmed-article:16536638pubmed:authorsCompleteYlld:pubmed
pubmed-article:16536638pubmed:pagination167-78lld:pubmed
pubmed-article:16536638pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:meshHeadingpubmed-meshheading:16536638...lld:pubmed
pubmed-article:16536638pubmed:year2006lld:pubmed
pubmed-article:16536638pubmed:articleTitleLong-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.lld:pubmed
pubmed-article:16536638pubmed:affiliationDenver Arthritis Clinic, University of Colorado, Denver, Colorado 80230, USA. crendon@denverarthritisclinic.comlld:pubmed
pubmed-article:16536638pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16536638pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16536638pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed